In addition, midostaurin induced apoptosis and downregulation of CD2 and CD63 [59] and inhibited IgE-dependent upregulation of CD63 in the mast cell leukemia cell line HMC-1 [60], resulting in enhanced inhibition of cell growth. Here, CD63 is linked to mast cell leukemia.